Tormere Analytics
OverviewStock ResearchPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Pricing
Privacy PolicyTerms of Service

NRSN

$0.33-17.21%website ↗

NeuroSense Therapeutics Ltd.

Market Cap
$13M
Sector
Materials
Industry
Biotechnology
Beta
1.59
5yr monthly vs SPY
Price Chart
Loading…

Signals

Insider Velocity
24.0x
buying
Congress
—
recent trades
Short Volume
42%
W/W +28.7pp

Market & Alt Data

News
15
recent articles
Activist
—
none active
Analyst Consensus
Strong Buy
9 analysts
Velocity Score
23.98x
Current Rate (90d)
2777.78/mo
Baseline Rate
0.00/mo
Unique Buyers (90d)
1
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-06-162026-06-17Ben-Noon AlonChief Executive OfficerPurchase250.0K$0.80$200K4.53MView

Recent News

NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance · 2026-09-10
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 2026-09-09
NeuroSense Therapeutics Announces 1-For-20 Reverse Stock Split, Effective Sept. 14
Benzinga · 2026-09-09
This SpaceX Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Benzinga · 2026-09-08

Informational purposes only, not investment advice.

Which stocks are experiencing notable movement on Friday?
ChartMill · 2026-09-04
These stocks are moving in today's session
ChartMill · 2026-09-04
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 2026-09-04
This Occidental Petroleum Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Benzinga · 2026-09-03
HC Wainwright & Co. Initiates Coverage On NeuroSense Therapeutics with Buy Rating, Announces Price Target of $8
Benzinga · 2026-09-03
NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS
Yahoo · 2026-08-31
NeuroSense Announces Redesigned Development Plan For PrimeC In Amyotrophic Lateral Sclerosis, Structured To Reach Potential Path For Regulatory Submission And Faster Approval
Benzinga · 2026-08-31
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 2026-08-25
NeuroSense Issues CEO Letter to Shareholders
Yahoo · 2026-08-13
NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada
Yahoo Finance · 2026-08-06
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS
Yahoo Finance · 2026-07-22

Factor Profile

Pro
Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →